Article
Clinical treatment of hospital-acquired pneumonia caused by extensively drug-resistant Acinetobacter baumannii: single-centre retrospective study
2021-04-27
Abstract excerpt
<h4>Background: </h4> Extensively drug-resistant Acinetobacter baumannii (XDRAB) has strong ability to acquire drug resistance genes, which are then rapidly cloned and transmitted, leading to worldwide spread posing a significant treatment challenge. Currently, limited drugs are available for the treatment of XDRAB infection, and their clinical effects are not clear; therefore, the specific factors that affect the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3649ea61-2b80-580f-89e7-fa2914bc8843
- DOI
- 10.21203/rs.3.rs-441648/v1
